Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e87f29e0db9416800cab4f60f6c468 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 |
filingDate |
2007-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0be146b556bdbbc29691a975f391eec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eef97df399e3ab7ce9d7df6079786f84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a04fbf0b153174865b41bd129a29e5c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6dec208e8bc8b1483c2dedca8c4b8ebc |
publicationDate |
2008-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2662938-A1 |
titleOfInvention |
Light-stable solid pharmaceutical composition of ramosetron |
abstract |
Disclosed is a ramosetron preparation which is stable under irradiation with light. Specifically disclosed is a solid pharmaceutical composition prepared by adding a compound capable of absorbing a light having a specific wavelength to ramosetron which is unstable under irradiation with light or a pharmaceutically acceptable salt thereof. Thus, a stable preparation can be provided. This technique is useful because it is adaptable to a preparation containing ramosetron or a pharmaceutically acceptable salt thereof at a low content or an orally degradable tablet containing ramosetron or a pharmaceutically acceptable salt thereof. Also disclosed is a method for stabilizing a solid pharmaceutical composition comprising ramosetron or a pharmaceutically acceptable salt thereof, which is characterized by adding a compound capable of absorbing a light having a specific wavelength. |
priorityDate |
2006-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |